María Pilar Mejías

Differential expression of the fractalkine chemokine receptor (CX3CR1) in human monocytes during differentiation

Cecilia A. Panek, María Victoria Carballo Calero Ramos, María Pilar Mejías et al. · Cellular and Molecular Immunology · 2014 · 73 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Development of camelid single chain antibodies against Shiga toxin type 2 (Stx2) with therapeutic potential against Hemolytic Uremic Syndrome (HUS)

María Pilar Mejías, Yanina Hiriart, Constanza Lauché et al. · Scientific Reports · 2016 · 64 citations · Full text

Pharmacy, Biotechnology, Immunology +17

Immunization with a Chimera Consisting of the B Subunit of Shiga Toxin Type 2 and Brucella Lumazine Synthase Confers Total Protection against Shiga Toxins in Mice

María Pilar Mejías, Giselle Ghersi, Patricio O. Craig et al. · The Journal of Immunology · 2013 · 56 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Induction of Neutrophil Extracellular Traps in Shiga Toxin-Associated Hemolytic Uremic Syndrome

María Victoria Carballo Calero Ramos, María Pilar Mejías, Florencia Sabbione et al. · Journal of Innate Immunity · 2016 · 47 citations · Full text

Medicine, Pathobiology, Pathology +17

The oxidative stress induced <i>in vivo</i> by Shiga toxin-2 contributes to the pathogenicity of haemolytic uraemic syndrome

Sonia Gómez, María Jimena Abrey-Recalde, Cecilia A. Panek et al. · Clinical & Experimental Immunology · 2013 · 43 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +17